Volume 19, Number 3—March 2013
Perspective
Measles Elimination Efforts and 2008–2011 Outbreak, France
Denise Antona
, Daniel Lévy-Bruhl, Claire Baudon, François Freymuth, Mathieu Lamy, Catherine Maine, Daniel Floret, and Isabelle Parent du Chatelet
, Daniel Lévy-Bruhl, Claire Baudon, François Freymuth, Mathieu Lamy, Catherine Maine, Daniel Floret, and Isabelle Parent du Chatelet
Table
Measles-related complications among 4,968 hospitalized patients, by age group, France, January 2008–December 2011*
| Complications | No. (%) patients, by age group, y |
p value† | ||||
|---|---|---|---|---|---|---|
| <1, n = 470 | 1–14, n = 1,150 | 15–29, n = 2,290 | >30, n = 1,058 | Total, n = 4,968 | ||
| All complications |
130 (27.7) |
373 (32.4) |
669 (29.2) |
441 (41.7) |
1,613 (32.5) |
<0.001 |
| Pulmonary | ||||||
| Pneumonia | 75 (15.9) | 227 (19.7) | 416 (18.2) | 305 (28.8) | 1,023 (20.6) | <0.001 |
| Other‡ |
1 (0.2) |
21 (1.8) |
32 (1.4) |
15 (1.4) |
69 (1.4) |
NS |
| Ear, nose, throat | ||||||
| Otitis media | 24 (5.1) | 27 (2.3) | 11 (0.5) | 2 (0.2) | 64 (1.3) | <0.001 |
| Other‡ |
6 (1.3) |
12 (1.0) |
11 (0.5) |
5 (0.5) |
34 (0.7) |
NS |
| Digestive tract | ||||||
| Diarrhea/dehydration | 3 (0.6) | 26 (2.3) | 30 (1.3) | 19 (1.8) | 78 (1.5) | NS |
| Liver or pancreas disorder | 1 (0.2) | 5 (0.4) | 105 (4.6) | 70 (6.6) | 181 (3.6) | <0.001 |
| Other‡ |
11 (2.3) |
18 (1.6) |
19 (0.8) |
5 (0.5) |
53 (1.1) |
NS |
| Neurologic | ||||||
| Encephalitis or myelitis | 0 | 10 (1.1) | 13 (0.6) | 4 (0.4) | 27 (0.5) | NS |
| Other‡ |
2 (0.4) |
10 (0.9) |
8 (0.3) |
1 (0.1) |
21 (0.4) |
NT |
| Keratitis |
0 |
1 (0.1) |
9 (0.4) |
6 (0.6) |
16 (0.3) |
|
| Other‡ | 10 (0.2) | 21 (1.8) | 32 (1.4) | 17 (1.6) | 80 (1.6) | NS |
| Death | 0 | 2 (0.2) | 6 (0.3) | 2 (0.2) | 10 (0.2) | NT |
*Total excludes 12 patients with unknown date of birth. NS, not significant; NT, not tested (expected value <5).
†By χ2 test.
‡Other complications (numbers in brackets indicate no. cases of that complication identified): pulmonary (e.g., bronchitis, pleurisy); ear, nose, throat (e.g., tonsillitis, sinusitis); digestive tract (e.g., vomiting, dysphagia, abdominal ache); neurologic (e.g., Guillain-Barré syndrome [1], meningitis); other (e.g., miscarriage [5], premature delivery [3], neonatal infection [4], myocarditis/pericarditis [8], general state impairment [42], thrombocytopenia [18]).
Page created: February 13, 2013
Page updated: February 13, 2013
Page reviewed: February 13, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.